← Back to guidelines
Gastroenterology1 paper

Carcinoma of greater curve of stomach

Last edited: 4/10/2026

Overview

Gastric cancer (GC) is a leading cause of preventable cancer and mortality in certain US populations 1. Primary prevention through Helicobacter pylori eradication and secondary prevention via endoscopic screening and surveillance of precancerous conditions are impactful strategies to reduce GC incidence and mortality 1.

Diagnosis

  • No specific diagnostic criteria for carcinoma of the greater curve of the stomach were provided in the abstracts.
  • The abstracts focus on screening and surveillance for gastric cancer in general, particularly for individuals at increased risk 1.
  • Management

    Primary prevention includes Helicobacter pylori* eradication 1.
  • Secondary prevention involves endoscopic screening and surveillance of precancerous conditions like gastric intestinal metaplasia (GIM) 1.
  • Special Populations

  • No specific information on special populations was provided in the abstracts.
  • Key Recommendations

  • Primary prevention of gastric cancer should include Helicobacter pylori eradication 1. (Evidence: Expert opinion)
  • Secondary prevention of gastric cancer should involve endoscopic screening and surveillance of precancerous conditions, such as gastric intestinal metaplasia 1. (Evidence: Expert opinion)
  • References

    1 Shah SC, Wang AY, Wallace MB, Hwang JH. AGA Clinical Practice Update on Screening and Surveillance in Individuals at Increased Risk for Gastric Cancer in the United States: Expert Review. Gastroenterology 2025. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG